NCT05583617 A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05581875 A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT05573802 A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT05572515 A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05567094 The Effect of Perioperative DEXamethasone on Postoperative Complications After PANcreaticoduodenectomy Status COMPLETED Phase PHASE4
NCT05564286 Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer Status COMPLETED Phase PHASE3
NCT05561387 Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment Status RECRUITING Phase PHASE3
NCT05560399 A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05558319 NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide Status NOT_YET_RECRUITING Phase PHASE3
NCT05553496 Assessment of Rituximab Therapeutic Response Versus Conventional Treatment Status UNKNOWN Phase PHASE2/PHASE3
NCT05552976 A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05552222 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma Status RECRUITING Phase PHASE3
NCT05549895 Effect of Intrathecal Dexamethasone on Intra-operative Hemodynamic in Elderly Patients Undergoing Urologic Endoscopic Surgery Status UNKNOWN Phase PHASE4
NCT05546359 Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients Status COMPLETED Phase PHASE2/PHASE3
NCT05546060 Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH Status UNKNOWN Phase PHASE1
NCT05533281 Efficacy of Three Antiemetics in Preventing Nausea and Vomiting Status COMPLETED Phase PHASE4
NCT05530811 Dexamethasone as Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block Status UNKNOWN Phase NA
NCT05530421 Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma Status RECRUITING Phase PHASE2
NCT05527340 Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05524038 Comparison Between the Quadratus Lumborum Block ,Erector Spinae Plane Block in Lower Abdominal Surgery Status COMPLETED Phase NA